This site is intended for healthcare professionals
Paediatric Dermatitis
Pediatric Atopic Dermatitis
Declaration of sponsorship Sanofi & Regeneron

Disease Burden

Declaration of sponsorship Sanofi & Regeneron
Read time: 10 mins
Last updated:10th Nov 2022
Published:10th Nov 2022

Disease Burden in Pediatric Atopic Dermatitis Patients and Their Caregivers

Moderate-to-severe atopic dermatitis (AD) imposes a multidimensional disease burden that includes itch, sleep disturbance, mental health impairments, and various multimorbid conditions, all of which can impact quality of life (QOL). Caregivers of pediatric patients with moderate-to-severe AD are also affected by the disease, with reduced QOL, loss of sleep, and increased risk for symptoms of anxiety and depression.1-11

Join Professor Antonella Muraro and learn how AD imposes a multidimensional disease burden in pediatric patients and caregivers.

  1. Overview of Disease Burden in Pediatric Patients and Caregivers with Atopic Dermatitis (0:12)
    Antonella Muraro, EAACI 2022
  2. Disease Impact on Patients (EPI-CARE) (00:58)
    Antonella Muraro, EAACI 2022
  3. Disease Impact on Caregivers (EPI-CARE) (02:14)
    Antonella Muraro, EAACI 2022

References

  1. Paller AS, et al. J Am Acad Dermatol. S0190-9622(22)00092-5. Epub 2022 Jan 23.
  2. Ramirez FD, et al. JAMA Pediatr. 2019;173(5):e190025.
  3. Weidinger S, et al. Poster presented at ESPD, 20–22 May 2022; Munich, Germany.
  4. Silverberg JI, et al. Poster presented at EADV; September 7–10, 2022; Milan, Italy.
  5. Shah S, et al. Poster presented at SID Annual Meeting; May 18–21, 2022; Portland, OR, USA.
  6. Weidinger S, et al. Poster presented at SPD virtual conference; 8–10 July 2021.
  7. Hou A, Silverberg JI. Pediatr Dermatol. 2021;38(3):606-612.
  8. Stingeni L, et al. J Asthma Allergy. 2021;14:919-928.
  9. Barbarot S, et al. J Pediatr. 2022;246:220-226.e5.
  10. Wu Di, et al. Ann Transl Med. 2021;9(1):40.
  11. Capozza K, et al. Dermatitis 2020;31(3):223-227.
Welcome: